A multi-center, phase 1-2A, open-label, dosage-escalation and randomized, double-blinded, placebo-controlled study of dimebon [dimebolin] in subjects with Huntington's disease.
Phase of Trial: Phase I/II
Latest Information Update: 14 Apr 2009
At a glance
- Drugs Latrepirdine (Primary)
- Indications Huntington's disease
- Focus Adverse reactions
- Acronyms DIMOND
- Sponsors Medivation
- 14 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Feb 2008 Status changed from completed to in progress as Medivation have reported that the phase II part is ongoing.
- 19 Feb 2008 Medivation have reported that the phase I tolerability part of this trial has been completed.